%0 Journal Article
%T Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
%A Adi Diab
%A Alexandre Reuben
%A Arlene H. Sharpe
%A Cara Haymaker
%A Christine N. Spencer
%A Dennie T. Frederick
%A Edwin R. Parra
%A Hong Jiang
%A Ignacio I. Wistuba
%A Isabella C. Glitza
%A Jacob L. Austin-Breneman
%A Jaime Rodriguez-Canales
%A James P. Allison
%A Jeffrey E. Gershenwald
%A Jennifer A. Wargo
%A Karen Clise-Dwyer
%A Keith T. Flaherty
%A Lisa M. Coussens
%A Luis M. Vence
%A Lynda Chin
%A Michael A. Davies
%A Michael T. Tetzlaff
%A Padmanee Sharma
%A Patrick Hwu
%A Peter A. Prieto
%A Rodabe N. Amaria
%A Ryan J. Sullivan
%A Sapna P. Patel
%A Scott E. Woodman
%A Vancheswaran Gopalakrishnan
%A Zachary A. Cooper
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2015.1136044
%K Immune checkpoint blockade
%K melanoma
%K targeted therapy
%K BRAF
%K CTLA-4
%K PD-1
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839346/